Article
T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
18 Jun 2012
Abstract excerpt
The genetic modification of T cells with a suicide gene grants a mechanism of control of adverse reactions, allowing safe infusion after partially incompatible hematopoietic stem cell transplantation (HSCT). In the TK007 clinical trial, 22 adults with hematologic malignancies experienced a rapid and sustained immune recovery after T cell-depleted HSCT and serial infusions of purified donor T cells expressing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
